GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guard Therapeutics International AB (OSTO:GUARD) » Definitions » Cash Flow from Others

Guard Therapeutics International AB (OSTO:GUARD) Cash Flow from Others : kr4.96 Mil (TTM As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Guard Therapeutics International AB Cash Flow from Others?

Guard Therapeutics International AB's cash flow from others for the three months ended in Mar. 2024 was kr1.13 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Mar. 2024 was kr4.96 Mil.


Guard Therapeutics International AB Cash Flow from Others Historical Data

The historical data trend for Guard Therapeutics International AB's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guard Therapeutics International AB Cash Flow from Others Chart

Guard Therapeutics International AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Others
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.86 -0.01 0.54 0.81 4.83

Guard Therapeutics International AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.01 1.36 1.48 0.99 1.13

Guard Therapeutics International AB Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr4.96 Mil.

Guard Therapeutics International AB Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Guard Therapeutics International AB's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Guard Therapeutics International AB (OSTO:GUARD) Business Description

Traded in Other Exchanges
N/A
Address
Scheelevagen 22, Lund, SWE, 223 63
Guard Therapeutics International AB is engaged in developing and commercializing the lead drug candidate ROSgard, and thereby contribute to the better and less harmful treatment of acute kidney injuries.

Guard Therapeutics International AB (OSTO:GUARD) Headlines

No Headlines